Moreover, the present findings suggest that the monitoring and the modulation of KCTD15 expression and activity can be effectively used for both diagnostic/prognostic and therapeutic scopes with a specific focus on HER2+ BC. This evidence concerns the gene KCTD15 and breast cancer.